Cargando…
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
Autores principales: | Liu, Xu-Sheng, Zhou, Lu-Meng, Yuan, Ling-Ling, Gao, Yan, Kui, Xue-Yan, Liu, Xiao-Yu, Pei, Zhi-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439576/ https://www.ncbi.nlm.nih.gov/pubmed/34531879 http://dx.doi.org/10.3389/fimmu.2021.751004 |
Ejemplares similares
-
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021) -
ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma
por: Zhang, Yao-Hua, et al.
Publicado: (2022) -
Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma
por: Liu, Xu-Sheng, et al.
Publicado: (2021) -
Interaction between glycolysis‒cholesterol synthesis axis and tumor microenvironment reveal that gamma-glutamyl hydrolase suppresses glycolysis in colon cancer
por: Chen, Yan-Jie, et al.
Publicado: (2022) -
The significance of glycolysis index and its correlations with immune infiltrates in Alzheimer’s disease
por: Qiu, Zhiqiang, et al.
Publicado: (2022)